Atnaujinkite slapukų nuostatas

Cellular and Molecular Pathobiology of Cardiovascular Disease [Kietas viršelis]

Edited by (University of North Carolina, Chapel Hill, NC, USA), Edited by (University of North Carolina, Chapel Hill, USA), Edited by (Harvard Medical School, Boston, MA, USA)
  • Formatas: Hardback, 338 pages, aukštis x plotis: 276x216 mm, weight: 1170 g
  • Išleidimo metai: 06-Mar-2014
  • Leidėjas: Academic Press Inc
  • ISBN-10: 0124052061
  • ISBN-13: 9780124052062
Kitos knygos pagal šią temą:
  • Formatas: Hardback, 338 pages, aukštis x plotis: 276x216 mm, weight: 1170 g
  • Išleidimo metai: 06-Mar-2014
  • Leidėjas: Academic Press Inc
  • ISBN-10: 0124052061
  • ISBN-13: 9780124052062
Kitos knygos pagal šią temą:
The textbook is designed to complement standard anatomic cardiovascular textbooks by discussing some areas that are not usually included in them. Among the topics are: the molecular basis of cardiac development; cardiac atrophy and remodeling; the pathophysiology of cardiac hypertrophy and heart failure; ischemic heart disease and its consequences; the cellular and molecular pathobiology of the cardiac conduction system; calcific and degenerative heart valve disease; vasculogenesis and angiogenesis; diseases of medium-sized and small vessels; blood pressure regulation and pathology; and the pericardium and its diseases. Annotation ©2014 Ringgold, Inc., Portland, OR (protoview.com)

Cellular and Molecular Pathobiology of Cardiovascular Disease focuses on the pathophysiology of common cardiovascular disease in the context of its underlying mechanisms and molecular biology. This book has been developed from the editors' experiences teaching an advanced cardiovascular pathology course for PhD trainees in the biomedical sciences, and trainees in cardiology, pathology, public health, and veterinary medicine. No other single text-reference combines clinical cardiology and cardiovascular pathology with enough molecular content for graduate students in both biomedical research and clinical departments.

The text is complemented and supported by a rich variety of photomicrographs, diagrams of molecular relationships, and tables. It is uniquely useful to a wide audience of graduate students and post-doctoral fellows in areas from pathology to physiology, genetics, pharmacology, and more, as well as medical residents in pathology, laboratory medicine, internal medicine, cardiovascular surgery, and cardiology.

  • Explains how to identify cardiovascular pathologies and compare with normal physiology to aid research
  • Gives concise explanations of key issues and background reading suggestions
  • Covers molecular bases of diseases for better understanding of molecular events that precede or accompany the development of pathology

Recenzijos

"The images and illustration quality are exceptional, with a plethora of molecular and biochemical information related to each topic. Readers looking for a detailed reference for participation in research or for a presentation will find this a great resource. Rating: 3 Stars"--Doody's.com, September 5 2014 

"designed to complement standard anatomic cardiovascular textbooks by discussing some areas that are not usually included in them. Among the topics are: the molecular basis of cardiac development; cardiac atrophy and remodeling; the pathophysiology of cardiac hypertrophy and heart failure; ischemic heart disease and its consequences"--ProtoView.com, April 2014

Daugiau informacijos

Biomedical text-reference offers translational coverage of cardiovascular physiology, pathophysiology, and molecular pathology
Foreword xi
Preface xiii
Contributors xv
Acknowledgments xvii
1 Molecular Basis of Cardiac Development
Laura A. Dyer
Ivan Moskowitz
Cam Patterson
The Heart Fields and Heart Tube Formation
1(3)
Looping and Laterality
4(2)
Chamber Specification
6(1)
Ventricular Septation and Myocardial Patterning
7(1)
Conduction System Development
8(1)
Valve Development
9(2)
Atrial Septation
11(2)
Arterial Pole Maturation
13(2)
Epicardial and Coronary Vascular Development
15(1)
Conclusions
16(1)
Acknowledgments
17(1)
References
17(6)
2 Cardiac Metabolism in Health and Disease
Lionel H. Opie
Introduction
23(1)
Energy Availability
23(1)
Major Sources of Energy
23(6)
Energy Expenditure: Work of the Heart
29(1)
Pathological Alterations in Myocardial Energy Metabolism
30(3)
Metabolism of Heart Failure
33(1)
Mitochondrial Mechanisms in Heart Disease
34(1)
References
35(2)
3 Cardiac Atrophy and Remodeling
Pamela A. Harvey
Leslie A. Leinwand
Overview of Atrophic Cardiac Remodeling
37(1)
Models of Atrophic Remodeling
37(1)
Cardiac Workload Determines Cardiac Size
38(1)
Morphological Features of the Atrophic Heart
39(1)
Extracellular Matrix Remodeling with Cardiac Atrophy
40(1)
Protein Homeostasis in the Healthy and Atrophic Heart
41(1)
Metabolic Unloading of the Myocardium
42(1)
Signaling Pathways Activated During Cardiac Atrophy
42(1)
Molecular Alterations in Atrophic Remodeling: The Fetal Gene Program
43(1)
Contractile Function in Cardiac Atrophy
44(1)
Regulation of Atrophic Remodeling by microRNAs
45(1)
Atrophic Remodeling due to Cardiac Pathology
45(2)
Atrophic Remodeling as a Potential Therapeutic
47(1)
Summary
47(1)
References
48(3)
4 The Pathophysiology of Cardiac Hypertrophy and Heart Failure
William E. Stansfield
Mark Ranek
Avani Pendse
Jonathan C. Schisler
Shaobin Wang
Thomas Pulinilkunnil
Monte S. Willis
Introduction
51(1)
Etiology of Heart Failure
51(2)
Physiologic Hypertrophy
53(4)
Pathologic Hypertrophy
57(1)
Molecular Mechanisms of Pathologic LVH
58(12)
References
70(9)
5 Ischemic Heart Disease and its Consequences
John W. Calvert
Introduction
79(1)
Pathophysiology of Ischemia--Reperfusion Injury
79(6)
Therapeutic Strategies to Combat Myocardial Ischemia--Reperfusion Injury
85(10)
Clinical Trial Failure
95(2)
Summary and Concluding Remarks
97(1)
References
97(4)
6 Pathophysiology of Cardiomyopathies
Harsimran Saini
Sara Tabtabai
James R. Stone
Patrick T. Ellinor
Introduction
101(1)
Dilated Cardiomyopathy
101(1)
Ischemic Cardiomyopathy
102(1)
Idiopathic Dilated Cardiomyopathy
103(2)
Chagas Disease-Related Cardiomyopathy
105(1)
Alcoholic Cardiomyopathy
106(1)
Peripartum Cardiomyopathy
107(1)
Hypertrophic Cardiomyopathy
108(1)
Restrictive Cardiomyopathy
109(2)
Anderson-Fabry's Cardiomyopathy
111(1)
Cardiac Hemosiderosis
112(1)
Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
113(1)
Left Ventricular Non-Compaction Cardiomyopathy
114(1)
Role Of Genetic Testing and Future Directions
115(1)
References
116(5)
7 Cellular and Molecular Pathobiology of the Cardiac Conduction System
Thomas J. Hund
Sakima A. Smith
Michael A. Makara
Peter J. Mohler
Overview of the Cardiac Conduction System
121(1)
The Sinoatrial Node
122(3)
The Atrioventricular Node
125(2)
Bundle of His and Bundle Branches
127(1)
Cardiac Purkinje Fibers
127(1)
Role of Autonomic Nervous System
128(1)
Human Conduction System Disease
129(3)
MicroRNAs and Cardiac Conduction
132(1)
References
132(3)
8 Molecular Pathobiology of Myocarditis
Elisa Carturan
Cristina Basso
Gaetano Thiene
Introduction
135(1)
Etiology
136(3)
Diagnosis
139(7)
Pathogenic Mechanisms
146(7)
Treatment
153(1)
Consensus Statement on EMB from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology
154(1)
References
155(6)
9 Calcific and Degenerative Heart Valve Disease
Elena Aikawa
Frederick J. Schoen
Introduction
161(1)
Normal Valve Function, Biomechanics, and Structure
161(3)
Valve Development, Post-Developmental Adaptation, and Aging
164(2)
Calcific Aortic Valve Disease (CAVD)
166(2)
Mechanisms of CAVD
168(4)
Animal Models of CAVD
172(1)
Degenerative Mitral Valve Disease (DMVD)
172(3)
Mechanisms of DMVD
175(1)
Animal Models of Mitral Valve Disease
175(1)
Future Research Opportunities in Heart Valve Disease: Key Questions
176(1)
References
177(4)
10 Vasculogenesis and Angiogenesis
Joseph F. Arboleda-Velasquez
Patricia A. D'Amore
Introduction
181(1)
Vascular Development
181(2)
Developmental Abnormalities
183(3)
Angiogenic Component of Pathologies
186(5)
References
191(6)
11 Diseases of Medium-Sized and Small Vessels
J. Charles Jennette
James R. Stone
Introduction
197(1)
Normal Vessel Wall Structure
197(1)
Vascular Cell Activation
198(1)
Intimal Hyperplasia
199(3)
Diabetic Vasculopathy
202(1)
Amyloid Vasculopathy
203(2)
Small Vessel Vasculitis
205(7)
Kawasaki Disease
212(1)
Giant Cell Arteritis
213(1)
Vascular Trauma and the Hypothenar Hammer Syndrome
214(1)
Vasospasm and Raynaud's Phenomenon
215(2)
References
217(4)
12 Pathophysiology of Atherosclerosis
Michael A. Seidman
Richard N. Mitchell
James R. Stone
Introduction
221(1)
Early Lesions
222(1)
Lipids in Atherosclerosis
222(1)
Endothelial Activation
223(1)
Inflammation in Atherosclerosis
224(1)
The Atherosclerotic Plaque
225(3)
Aortic Atherosclerosis and Atherosclerotic Aneurysms
228(1)
The Genetics of Atherosclerosis
229(3)
Clinical Implications
232(2)
Laboratory and Animal Models
234(1)
Conclusions
235(1)
References
235(4)
13 Genetic Diseases of the Aorta (Including Aneurysms)
Marc K. Halushka
The Normal Aorta: Histology and Function
239(1)
Gross Pathologic Changes to the Aorta
240(1)
Demographics of Aneurysms and Dissections
241(1)
Histopathologic Changes to the Aorta
242(2)
Specific Genetic Syndromes and Causes of Aneurysm
244(5)
Non-Genetic Causes of Aortic Aneurysm
249(1)
Evidence for the TGF-β Pathway to be a Unifying Mechanism of Aortic Aneurysm
250(1)
TGF-β Canonical and Non-Canonical Signaling in the Ascending Aorta
250(1)
TGF-β Signaling in Ascending Aortic Diseases
251(1)
TGF-β Signaling in the Descending Aorta
252(1)
Biomarkers of Aneurysm
252(1)
Treatment for Aneurysm
253(1)
Future Directions
253(1)
References
253(4)
14 Blood Pressure Regulation and Pathology
Rhian M. Touyz
Introduction
257(1)
Definition of Essential (Primary) Hypertension
257(2)
Genetics of Hypertension
259(2)
Physiological Control of Blood Pressure
261(1)
Cardiac Output and Hypertension
261(1)
The Sympathetic Nervous System and Hypertension
261(1)
The Kidney and Hypertension
261(1)
Sodium and Hypertension
262(1)
The Renin--Angiotensin System (RAS)
262(2)
Angiotensin Receptors and Signaling
264(1)
The Vascular System and Hypertension
265(4)
Reactive Oxygen Species, Oxidative Stress, and Human Hypertension
269(1)
New Drugs, Procedures, and Devices in the Management of Hypertension
270(1)
Conclusions
271(1)
Acknowledgments
271(1)
References
271(6)
15 Venous and Arterial Thrombosis
Evi X. Stavrou
Alvin H. Schmaier
Introduction
277(1)
Venous Thrombosis
277(9)
Arterial Thrombosis
286(6)
References
292(5)
16 The Pericardium and its Diseases
Pooja Gupta
Amar Ibrahim
Jagdish Butany
The Pericardium and its Diseases
297(2)
Serological Tests
299(1)
Echocardiography
299(1)
Pericardiocentesis and Biopsy
299(1)
Specific Forms of Pericarditis
299(12)
References
311(4)
Index 315
Monte S. Willis, MD, PhD, MBA is Vice-Chair of Academic Affairs and Associate Professor in the Department of Pathology and Laboratory Medicine at the Univeristy of North Carolina-Chapel Hill. He is Director of Campus Health Services Laboratory and the McLendon Clinical Laboratories and principal investigator in the McAllister Heart Institute, where he leads a research team studying the role of the ubiquitin proteasome system in metabolism and the pathophysiology of cardiac disease (supported by NIH and the Fondation Leducq) and teaches in the School of Medicine and Graduate School. Dr. Willis received his combined MD and PhD training at the University of Nebraska Medical Center. He went on to complete a residency in the Department of Pathology and post-doctoral training in in Burns, Trauma, and Critical Care in the Department of Surgery at the University of Texas Southwestern Medical Center. He has received multiple honors for his research, including the Cotran Early Career Investigator Award from the American Society of Investigative Pathology, and the Jefferson-Pilot Fellowship in Academic Medicine from the University of North Carolina School of Medicine. He is active on the editorial boards of the American Journal of Pathology, Cardiovascular Pathology, Journal of Molecular and Cellular Cardiology, American Journal of Physiology-Endocrine and Metabolism and co-chairs an American Heart Association Study Section. Dr. Willis has published more than 210 manuscripts in clinical, translational, and the basic sciences and edited multiple medical textbooks, including Molecular and Translational Vascular Medicine (2012); Translational Cardiology: Molecular Basis of Cardiac Metabolism, Cardiac Remodeling, Translational Therapies, and Imaging Techniques (2012), and the Cellular and Molecular Pathobiology of Cardiovascular disease (2013). Jonathon W. Homeister earned Bachelor of Arts degrees in Biology and Chemistry in 1985 from Hope College, where he began his research endeavors mentored by Christoper C. Barney, Ph.D. He then earned the Doctor of Philosophy in Pharmacology, mentored by Benedict R. Lucchesi, M.D., Ph.D., and the Doctor of Medicine from the University of Michigan in 1993. He received residency training in anatomic pathology at the University of Michigan Hospitals and is a Diplomat of the American Board of Pathology. After residency, he received additional research training as an Associate of the Howard Hughes Medical Institute, mentored by John B. Lowe, M.D. He is currently an Associate Professor in the Department of Pathology and Laboratory Medicine, and member of the McAllister Heart Institute at the University of North Carolina at Chapel Hill, where he is also Director of the Molecular and Cellular Pathology Graduate Program. His clinical interests include cardiovascular, autopsy, and forensic pathology, and his research interests focus on the glycobiology inherent to leukocyte trafficking, with particular respect to the pathogenesis of cardiovascular diseases including atherosclerosis and thrombosis. Dr. Stone graduated summa cum laude from Wabash College with a B.A. in chemistry. He then completed the Medical Scientist Training Program at the University of Michigan where he earned both an MD and a PhD in Biological Chemistry. His doctoral thesis research was performed in the laboratory of Prof. Michael A. Marletta, where he purified and characterized the sensor for nitric oxide, the soluble form of guanylate cyclase. Dr. Stone completed the Anatomic Pathology Residency Program at Brigham and Womens Hospital and Harvard Medical School. Dr. Stone completed clinical fellowship training in Cardiovascular Pathology at BWH under Prof. Frederick Schoen. He also completed post-doctoral research on endothelial cell biology in the Vascular Research Division at BWH and at Childrens Hospital with Prof. Tucker Collins. Dr. Stone is currently Head of the Cardiovascular Pathology Service and Director of the Autopsy Service at Massachusetts General Hospital. He is also an Associate Professor of Pathology at Harvard Medical School. Dr. Stone directs a research laboratory in the Center for Systems Biology at MGH studying mechanisms underlying cardiovascular diseases. His group has particular focus on vascular cell activation, vasculitis and atherosclerosis, and on bridging the gap between model systems and human cardiovascular diseases.